Proteome alteration and proteomic identification in serum of patients treated by continuous renal replacement therapy

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNC-08000164

Enrollment

Unknown

Registered

2008-10-29

Start date

2008-03-16

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe sepsis

Interventions

Patients with severe sepsis (before-after control):Continuous renal replacement therapy

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: The diagnosis of severe sepsis was based on the criteria of the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) Consensus Conference 1992 Committee and 2001 SCCM/ ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference.

Exclusion criteria

Exclusion criteria: The excluding criteria: patients with hypoproteinemia before admission; patients receiving corticosteroids in the past 4 weeks and patients with diabetes mellitus and acquired immune deficiency syndrome.

Design outcomes

Primary

Measure	Time frame
The serum proteome alterations (2-fold up-regulated or down-regulated) and identify proteins in serum;	—

Countries

China

Contacts

Public ContactGong Yu

gongyuzj@yahoo.com.cn+86 0511 82182209

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026